Dechra Veterinary Products, located in Overland Park, Kansas is the U.S. sales and marketing division of Dechra Pharmaceuticals PLC, a UK listed company dedicated to the animal healthcare market. Dechra Veterinary Products’ companion animal portfolio focuses on endocrinology, dermatology, dental care, anesthesia, fluid therapy, pain management and joint health support. Our brands include VETORYL® Capsules (trilostane), ZYCORTAL® Suspension (desoxycorticosterone pivalate injectable suspension), FELIMAZOLE® (methimazole) Coated Tablets, ANIMAX® OINTMENT (nystatin, neomycin sulfate, thiostrepton, triamcinolone acetonide ointment), VETROPOLYCIN® (bacitracin-neomycin-polymyxin) Veterinary Ophthalmic Ointment and VETROPOLYCIN® HC (bacitracin-neomycin-polymyxin-hydrocortisone acetate 1%) Veterinary Ophthalmic Ointment, VETIVEX® line of parenteral fluids, and PHYCOX® joint health supplements. Dechra also offers a comprehensive line of topical veterinary products including MICONAHEX+Triz®, MALACETIC® and MAL-A-KET™ brands, plus a number of injectable anesthetics, oral anti-infectives and NSAIDs. Dechra’s equine portfolio includes OSPHOS® (clodronate injection), Orthokine® vet irap 10 and 60, Osteokine® (PRP), and EQUIDONE® (domperidone) Gel and PHYCOX® EQ joint health supplements. For more information, please visit www.dechra-us.com or call (866) 933-2472.